WEX Pharmaceuticals
WEX Pharmaceuticals Inc. is a late-stage drug development company in Vancouver, Canada dedicated to the research, development, manufacture, and commercialization of Halneuron®, a new novel non-opioid analgesic.
Halneuron® is a highly selective sodium channel blocker and represents a breakthrough in painkiller technology:
Non-addictive, no withdrawal symptoms and no euphoria No build of up of tolerance over time A long duration of pain relief with minimal side effects Safe for human use and tested in over 700 people to date
Halneuron® is entering into Phase III clinical trials for chemotherapy-induced neuropathic pain and concurrently being tested in other pain indications.
Halneuron® is a highly selective sodium channel blocker and represents a breakthrough in painkiller technology:
Halneuron® is entering into Phase III clinical trials for chemotherapy-induced neuropathic pain and concurrently being tested in other pain indications.
WEX Pharmaceuticals Offices
OnSite Workspace
Employees work from physical offices.
Typical time on-site:
None
Vancouver, British Columbia, CAN
